proadifen has been researched along with Leukopenia in 3 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gill, DP | 1 |
Kempen, RR | 1 |
Nash, JB | 1 |
Ellis, S | 1 |
Hayes, FD | 1 |
Short, RD | 1 |
Gibson, JE | 1 |
Solymoss, B | 1 |
Somogyi, A | 1 |
Kovács, K | 1 |
3 other studies available for proadifen and Leukopenia
Article | Year |
---|---|
Modifications of benzene myelotoxicity and metabolism by phenobarbital, SKF-525A and 3-methylcholanthrene.
Topics: Animals; Benzene; Leukocytosis; Leukopenia; Male; Methylcholanthrene; Phenobarbital; Phenols; Proadi | 1979 |
A correlation between cyclophosphamide induced leukopenia in mice and the presence of alkylating metabolites.
Topics: Alkylating Agents; Animals; Cyclophosphamide; Female; In Vitro Techniques; Kinetics; Leukocyte Count | 1972 |
Effect of spironolactone and proadifen on 7,12-dimethylbenz(a)anthracene-induced haematologic changes.
Topics: Animals; Benz(a)Anthracenes; Blood Cells; Blood Platelets; Bone Marrow Examination; Drug Antagonism; | 1971 |